Table 1.
Comparison of the casemix, management, and outcomes of patients treated for hip fracture in 2018–19 versus 2020
| 2018–2019 (n = 172) |
2020 (n = 64) |
p value | |
|---|---|---|---|
| Age, years (SD) | 84.1 (7.8) | 83.9 (9.8) | 0.837 |
| Sex, female (%) | 114 (66.3) | 42 (65.6) | 0.925 |
| Residential status (%) | |||
| Nursing care | 20 (11.6) | 7 (10.9) | 0.307 |
| Functional status (%) | |||
| Independent | 98 (57.0) | 32 (50.0) | 0.479 |
| Partially dependent | 46 (26.8) | 23 (35.9) | |
| Dependent | 28 (16.3) | 9 (14.1) | |
| Cognitive status (%) | |||
| Cognitive impairment | 55 (32.2) | 21 (32.8) | 0.925 |
| Anaesthetic risk score (%) | |||
| ASA 3 or above | 128 (74.4) | 57 (89.1) | 0.015 |
| Anticoagulation/antiaggregation (%) | 0.706 | ||
| Overall | 52 (30.1) | 16 (25.0) | |
| Acenocumarol | 29 (16.9) | 11 (17.2) | |
| DOACs | 9 (5.2) | 2 (3.1) | |
| Clopidogrel/Ticagrelor | 14 (8.1) | 3 (4.7) | |
| Fracture type (%) | |||
| Intracapsular (OTA 31-B) | 82 (47.7) | 29 (45.4) | 0.145 |
| Intertrochanteric (OTA 31-A) | 80 (46.5) | 30 (46.9) | |
| Subtrochanteric (OTA 32(A-C)) | 10 (5.8) | 5 (7.8) | |
| Spinal anaesthesia (%) | 154 (92.2) | 60 (93.8) | 0.689 |
| Mobilized by the first postoperative day (%) | 36 (20.9) | 13 (20.3) | 0.917 |
| Destination at discharge (%) | |||
| Deceased in-hospital | 8 (4.7) | 5 (7.8) | 0.344 |
| Geriatric rehabilitation unit | 81 (47.1) | 4 (6.2) | < 0.001 |
| Nursing home | 23 (13.4) | 12 (18.8) | 0.301 |
| Private home | 60 (34.9) | 43 (67.2) | < 0,001 |
| Surgical delay, median hours (IQR) | 91.3 (50.0–136.0) | 50.5 (32.1–109.2) | 0.002 |
| Length of stay, median days (IQR) | 14.0 (10.0–19.0) | 9.0 (6.3–15.5) | < 0.001 |
| Mortality (%) | |||
| 30-day mortality | 9 (5.2) | 7 (10.9) | 0.121 |
| 90-day mortality | 16 (9.3) | 10 (15.6) | 0.193 |